Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Lyra Therapeutics (LYRA) Change in Account Payables (2021 - 2025)

Lyra Therapeutics has reported Change in Account Payables over the past 5 years, most recently at $103000.0 for Q4 2025.

  • Quarterly results put Change in Account Payables at $103000.0 for Q4 2025, up 109.25% from a year ago — trailing twelve months through Dec 2025 was -$516000.0 (up 72.66% YoY), and the annual figure for FY2025 was -$516000.0, up 72.66%.
  • Change in Account Payables for Q4 2025 was $103000.0 at Lyra Therapeutics, up from -$120000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for LYRA hit a ceiling of $3.3 million in Q1 2023 and a floor of -$3.5 million in Q4 2023.
  • Median Change in Account Payables over the past 5 years was -$75500.0 (2023), compared with a mean of -$100700.0.
  • Biggest five-year swings in Change in Account Payables: tumbled 435.4% in 2022 and later skyrocketed 2343.4% in 2024.
  • Lyra Therapeutics' Change in Account Payables stood at $1.2 million in 2021, then crashed by 289.69% to -$2.2 million in 2022, then crashed by 57.53% to -$3.5 million in 2023, then skyrocketed by 68.51% to -$1.1 million in 2024, then surged by 109.25% to $103000.0 in 2025.
  • The last three reported values for Change in Account Payables were $103000.0 (Q4 2025), -$120000.0 (Q3 2025), and -$45000.0 (Q2 2025) per Business Quant data.